남성 유방암 치료 시장 규모, 점유율, 성장 분석 : 유형별, 제품 유형별, 치료별, 진단별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)

Global Male Breast Cancer Treatment Market size was valued at USD 4.4 billion in 2023 and is poised to grow from USD 4.56 billion in 2024 to USD 6.1 billion by 2032, growing at a CAGR of 3.7% during the forecast period (2025-2032).

Male breast cancer, although rare, is emerging as a significant concern, particularly as the population ages and obesity rates rise. This cancer type arises from rapid cell division in breast tissue, often linked to genetic mutations such as BRCA2, predominantly affecting older men, with 1 in 833 at risk over their lifetime. Interestingly, it accounts for less than 1% of all cancers. However, increased awareness has improved survival rates through early diagnosis and effective treatment options. Key market drivers include a rise in cancer cases and advancements in biotechnology, as evidenced by collaborations like that of Bristol-Myers Squibb and Clovis Oncology. However, challenges remain, such as the high cost of research and the lack of a cohesive treatment strategy, which may hinder market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Male Breast Cancer Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Male Breast Cancer Treatment Market Segmental Analysis

Global Male Breast Cancer Treatment Market is segmented by Type, Product Type, Treatment, Diagnosis, End User and region. Based on Type, the market is segmented into Ductal Carcinoma in Situ, Paget's Disease of the Nipple, Inflammatory Breast Cancer, Infiltrating Ductal carcinoma and Others. Based on Product Type, the market is segmented into Chemotherapy, Medication and Others. Based on Treatment, the market is segmented into Local Treatments, Radiation Therapy, Targeted Therapy and Systemic Treatments. Based on Diagnosis, the market is segmented into Mammography, Biopsy, Fine Needle Aspiration Biopsy, Core Biopsy, Excisional Biopsy, PET Scan, CT Scan, MRI Scan and Other Tests. Based on End User, the market is segmented into Hospitals, Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Male Breast Cancer Treatment Market

The global market for male breast cancer treatment is significantly driven by rising awareness and enhanced early detection efforts. Initiatives and campaigns aimed at educating the public have played a crucial role in promoting the importance of recognizing the signs of male breast cancer, leading to timely diagnoses. Early detection is fundamental to improving survival rates and treatment success, as it enables healthcare providers to initiate appropriate therapies sooner. Furthermore, advancements in diagnostic technologies and the implementation of comprehensive screening programs have contributed to better patient outcomes, underscoring the critical importance of awareness in combating this rare condition.

Restraints in the Global Male Breast Cancer Treatment Market

The Global Male Breast Cancer Treatment market faces significant restraints due to the limited number of clinical trials and research focused specifically on male patients. This is largely because male breast cancer is rarer than female breast cancer, resulting in insufficient gender-specific research to inform treatment protocols. Consequently, treatment options may be based primarily on data derived from studies primarily involving women, which may not effectively address the unique needs of male patients. This scarcity of targeted research creates challenges in formulating optimal care plans and can potentially compromise the effectiveness of treatments intended for men diagnosed with breast cancer.

Market Trends of the Global Male Breast Cancer Treatment Market

The Global Male Breast Cancer Treatment market is experiencing a significant transformation driven by rising awareness and the evolving oncology landscape. Historically overshadowed by female breast cancer, the increasing recognition of male breast cancer has prompted dedicated research and development initiatives. Notably, a surge in male breast cancer cases has catalyzed the medical community to allocate resources towards specialized treatments and innovative therapies. This paradigm shift is fostering collaboration among researchers, clinicians, and advocates, culminating in enhanced early detection, personalized treatment options, and improved outcomes for affected men. The market is poised for growth as it increasingly focuses on addressing this unique patient demographic.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Male Breast Cancer Treatment Market Size by Type & CAGR (2025-2032)

• Market Overview
• Ductal Carcinoma in Situ
• Paget's Disease of the Nipple
• Inflammatory Breast Cancer
• Infiltrating Ductal carcinoma
• Others

Global Male Breast Cancer Treatment Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Chemotherapy
• Medication
• Others

Global Male Breast Cancer Treatment Market Size by Treatment & CAGR (2025-2032)

• Market Overview
• Local Treatments
• Radiation Therapy
• Targeted Therapy
• Systemic Treatments

Global Male Breast Cancer Treatment Market Size by Diagnosis & CAGR (2025-2032)

• Market Overview
• Mammography
• Biopsy
• Fine Needle Aspiration Biopsy
• Core Biopsy
• Excisional Biopsy
• PET Scan
• CT Scan
• MRI Scan
• Other Tests

Global Male Breast Cancer Treatment Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Clinics
• Others

Global Male Breast Cancer Treatment Market Size & CAGR (2025-2032)

• North America (Type, Product Type, Treatment, Diagnosis, End User)
  • US
  • Canada
• Europe (Type, Product Type, Treatment, Diagnosis, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Product Type, Treatment, Diagnosis, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Product Type, Treatment, Diagnosis, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Product Type, Treatment, Diagnosis, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bristol-Myers Squibb Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioNumerik Pharmaceuticals, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Seattle Genetics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Accord Healthcare Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius SE & Co. KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amgen Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations